EMPHASIS-HF

Posted by on

Eplerenone in patients with systolic heart failure and mild symptoms - The New England Journal of Medicine - 2011

Brief Summary:

Eplerenone reduces the risk of death and hospitalization in patients with moderate systolic dysfunction and NYHA class II symptoms.

Reference: http://www.ncbi.nlm.nih.gov/pubmed/21073363

Comments

Post a Comment

Drop your thoughts here, we would love to hear from you